GO
Loading...

Enter multiple symbols separated by commas

Stocks Abbott Laboratories

More

  • Aug 27- U.S. stocks extended their rally on Thursday, raising hopes that the worst of Wall Street's recent turmoil was behind it, after further evidence that the economy was on a solid footing. The market snapped a 6- day losing streak on Wednesday after New York Fed President William Dudley said the case for a September hike was "less compelling" after recent market...

  • US STOCKS-Wall St extends gains, helped by GDP data Thursday, 27 Aug 2015 | 10:06 AM ET

    *Second-qtr GDP rose 3.7 pct vs earlier reading of 2.3 pct. Aug 27- U.S. stocks rose sharply on Thursday, a day after posting their biggest one-day gain in four years, as data showed the U.S. economy grew faster in the second quarter than initially thought. While strong data points to increased chances of an interest rate hike in September, some investors said the...

  • *Second-qtr GDP rose 3.7 pct vs earlier reading of 2.3 pct. Aug 27- U.S. stocks were poised to open higher on Thursday, a day after posting their biggest one-day gain in four years, as data showed the U.S. economy grew faster in the second quarter than initially thought. "Despite the good GDP numbers that we saw today, September largely seems off the table because of the...

  • Aug 27- U.S. stock index futures rose sharply on Thursday, a day after Wall Street posted its biggest one-day gain in four years. *Stocks soared on Wednesday after New York Fed President William Dudley said the case for a September rate hike seemed "less compelling" than before. *Dudley's dovish comments came a day before many of the world's top central bankers gather...

  • NEW YORK, Aug 6- Generic drugmaker Mylan Inc's chief executive said on Thursday that acquiring Perrigo Co was not a must and that it has other options should Perrigo successfully fend off Mylan's $34 billion hostile offer. However, Mylan CEO Heather Bresch said in an interview that getting the Perrigo deal done remains a top priority and that she still believes...

  • Cramer: Johnson & Johnson needs to break up—NOW! Monday, 20 Jul 2015 | 6:35 PM ET
    Johnson & Johnson products

    Jim Cramer makes the case as to why Johnson & Johnson cannot wait another day to break itself up.

  • MUMBAI, July 16- India has extended price caps to an additional 39 drugs ranging from commonly used diabetes treatments to antibiotics, in the government's latest effort to improve the affordability of medicines. Wide-ranging price cuts over the past year have hit several drugmakers in India and have been opposed by many in the industry, who say drug prices in...

  • Two big problems with generic-drug substitution Tuesday, 23 Jun 2015 | 3:54 PM ET
    Pharmaceutical drugs

    Automatic generic-drug substitution poses several big problems, says NYU Professor Melissa Schilling.

  • TEL AVIV, June 23- Mylan NV chief financial officer John Sheehan will arrive in Israel on Wednesday for a meeting with the head of the Tel Aviv Stock Exchange to discuss a possible listing of its shares if it succeeds in buying Perrigo Co, an industry source said. Mylan has offered to acquire Perrigo for $34 billion in an attempt to fend off a bid from Israel's Teva...

  • June 16- Mylan NV's largest stakeholder, Abbott Laboratories, said it would back Mylan's proposed acquisition of Perrigo Co Plc, potentially helping Mylan fend of interest from Teva Pharmaceutical Industries Ltd. Abbott, which has a 14.5 percent stake in Mylan, said on Tuesday that it supported Mylan's "standalone strategy" and believed acquiring Perrigo...

  • Abbott to vote for Mylan's acquisition of Perrigo Tuesday, 16 Jun 2015 | 9:20 AM ET

    June 16- Abbott Laboratories said it would vote its 14.5 percent stake in Mylan NV in favor of Mylan's proposed acquisition of Perrigo Company Plc. Mylan's latest offer for Perrigo, worth $34.1 billion, is widely seen as an attempt to fend off Teva Pharmaceutical Industries Ltd, the world's biggest maker of generic drugs. Abbott, Mylan's largest shareholder, said...

  • Biotech isn't only health-care bet beating market Monday, 1 Jun 2015 | 10:09 AM ET
    An employee works on a stent graft component in a sterile environment at the Medtronic assembly plant in Tijuana, Mexico.

    The health-care sector is hot, and investors don't have to bet on the riskiest biotech stocks to profit.

  • Value investor: Bet on an eBay dividend Wednesday, 20 May 2015 | 7:28 AM ET

    Susan Byrne, founder and chairman of Westwood Holdings, is making a bet that eBay will likely issue a dividend following the spin off of PayPal.

  • A third of Pedialyte's sales now comes from adults Monday, 18 May 2015 | 7:24 PM ET
    Pedialyte a hangover cure? The company increases its focus on adult consumers.

    The drink once reserved for young kids has made new inroads with hungover adults.

  • Hungover? Pedialyte wants your business Wednesday, 13 May 2015 | 2:51 PM ET
    Pedialyte a hangover cure? The company increases its focus on adult consumers.

    Pedialyte is going after a new market, and they don't have a bedtime...

  • *Tie-up with Montreal scientists on heart disease genes. LONDON, May 13- AstraZeneca is diving deeper into personalised healthcare with two projects that move the concept beyond cancer into respiratory disorders and heart disease. To redress the balance, AstraZeneca said on Wednesday it had signed two deals, one with Abbott Laboratories for a diagnostic test...

  • May 5- Generic drugmaker Mylan NV, at the center of a high-stakes, three-way takeover battle, said on Tuesday it is fully committed to acquiring Ireland- based Perrigo Co and believes it can complete the deal by year end. Mylan, on a conference call with analysts, said it is legally committed to take its offer directly to Perrigo shareholders under Irish takeover...

  • May 5- Generic drugmaker Mylan NV, at the center of a high-stakes, three-way takeover battle, said on Tuesday it is fully committed to acquiring Ireland- based Perrigo Co.. "We remain steadfast in our legally binding commitment to acquire Perrigo and have taken numerous concrete steps to lay out a clear and certain path towards completion," Mylan Chief Executive...

  • May 5- Generic drugmaker Mylan NV, at the center of a high-stakes, three-way takeover battle, on Tuesday reported slightly higher-than-expected first-quarter profit and said it was "steadfast" in its commitment to acquire Ireland- based Perrigo Co.. Perrigo last week rejected a sweetened $34 billion offer from Mylan. At the same time, Mylan is attempting to fend...

  • April 22- Generic drugmaker Teva Pharmaceutical Industries Ltd said it could "promptly" divest some operations to obtain regulatory clearance for its proposed $40 billion takeover of smaller rival Mylan NV. Mylan, which has said a merger with Teva would be bad fit, plans to make a new offer for Perrigo Co Plc in the near term, CNBC reported on Wednesday.